Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Novel secondary hormonal therapy in advanced prostate cancer: An update
Eliezer M. Van Allen
,
Charles J. Ryan
Research output
:
Contribution to journal
›
Review article
›
peer-review
26
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel secondary hormonal therapy in advanced prostate cancer: An update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Advanced Prostate Cancer
100%
Secondary Hormonal Therapy
100%
Castration-resistant Prostate Cancer
66%
Antiandrogen
66%
Disease Progression
33%
Androgen Receptor
33%
Prostate Cancer
33%
Prostate Cancer Patients
33%
Androgen Deprivation Therapy
33%
Androgens
33%
Testosterone
33%
Targeted Treatment
33%
Clinical Approach
33%
Disease Process
33%
Inhibitor Compound
33%
Androgen Production
33%
Estrogenic
33%
Adrenal Androgens
33%
Hormonal Therapy
33%
Additional Therapy
33%
Castration Resistance
33%
Rapidly Evolving
33%
Medicine and Dentistry
Prostate Cancer
100%
Hormone Therapy
100%
Castration Resistant Prostate Cancer
50%
Antiandrogen
50%
Diseases
50%
Androgen Receptor
25%
Targeted Therapy
25%
Androgen Deprivation Therapy
25%
Disease Process
25%
Medical Decision Making
25%
Androgen Synthesis
25%
Estrogenic Compound
25%
Androgen
25%
Testosterone
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hormone Cancer Therapy
100%
Prostate Cancer
100%
Androgen
75%
Diseases
75%
Antiandrogen
50%
Castration Resistant Prostate Cancer
50%
Estrogenic Compound
25%
Androgen Receptor
25%
Testosterone
25%